Relay Therapeutics, Inc.
RLAY
$3.69
$0.288.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.68% | 5.31% | 8.97% | -34.03% | 6.39% |
| Total Depreciation and Amortization | -26.75% | -13.41% | -2.98% | 0.29% | 2.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.68% | -18.27% | 13.47% | 8.71% | -36.16% |
| Change in Net Operating Assets | -114.86% | -289.03% | 107.03% | 73.42% | 35.03% |
| Cash from Operations | 16.06% | -45.48% | 35.12% | 0.42% | 4.03% |
| Capital Expenditure | -136.36% | 78.43% | 100.00% | 61.53% | 99.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.99% | 248.05% | -51.51% | -275.02% | -13.68% |
| Cash from Investing | 64.97% | 303.24% | -51.41% | -276.78% | -11.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.65% | -- | -96.35% | 2,214.33% | -25.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.65% | -- | -96.35% | 2,214.33% | -25.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 209.59% | -436.75% | -269.73% | 225.18% | -22.94% |